Related Experiment Video
Updated: Mar 19, 2026

09:03
A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice
Published on: November 15, 2019
11.1K
Vision loss under silicone oil tamponade
Jan Tode1, Konstantine Purtskhvanidze2, Till Oppermann2
1Department of Ophthalmology, Christian-Albrechts-University of Kiel, University Medical Center, Arnold-Heller-Strasse 3, 24105, Kiel, Germany. jan.tode@uksh.de.
Summary
Silicone oil tamponade for retinal detachment can cause vision loss in some patients. Inner retinal thinning may explain this persistent vision impairment, even after oil removal.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Visual Neuroscience
Background:
- Rhegmatogenous retinal detachment (RRD) is a serious condition requiring surgical intervention.
- Silicone oil tamponade is a common method used during vitrectomy for RRD repair, particularly in complex cases.
- Understanding the long-term visual outcomes and potential complications of silicone oil use is crucial for patient management.
Purpose of the Study:
- To investigate the frequency, time course, and pathophysiology of vision loss in eyes with macula-on RRD treated with vitrectomy and silicone oil.
- To identify potential risk factors and underlying mechanisms contributing to visual impairment post-surgery.
Main Methods:
- A retrospective case series of 15 patients who underwent vitrectomy with 5,000 centistoke silicone oil tamponade for macula-on RRD.
- Comprehensive eye examinations including best corrected visual acuity (BCVA), visual field testing (VF), spectral domain optical coherence tomography (OCT), electrophysiology, and fluorescein angiography were performed.
Main Results:
- Vision loss, characterized by symptomatic central scotoma, occurred in 8 out of 15 eyes (53%).
- Optical coherence tomography revealed significant thinning of inner retinal layers (nerve fiber, ganglion cell, inner plexiform) in eyes with vision loss compared to healthy fellow eyes.
- While some patients experienced visual recovery, 3 out of 15 eyes (20%) had persistent vision loss (BCVA of 1.0) even after silicone oil removal.
Conclusions:
- Persisting vision loss occurs in a significant minority of patients treated for macula-on RRD with silicone oil.
- Inner retinal layer thinning, potentially induced by the silicone oil, is a likely pathophysiological explanation for this vision loss.
- Further research is warranted to elucidate the exact mechanisms and explore strategies to mitigate this complication.
Related Concept Videos
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

